Vaccine-Specific Immune Responses against Mycobacterium ulcerans Infection in a Low-Dose Murine Challenge Model
Kirstie M. Mangas, Andrew H. Buultjens, Jessica L. Porter, Sarah L. Baines, Estelle Marion, Laurent Marsollier, Nicholas J. Tobias, Sacha J. Pidot, et al. (15 authors)
Infection and Immunity · 2019-12
Abstract
0.05). To explore potential correlates of protection, a suite of 29 immune parameters were assessed in the mice at the end of the experimental period. Multivariate statistical approaches were used to interrogate the immune response data to develop disease-prognostic models. High levels of interleukin 2 (IL-2) and low gamma interferon (IFN-γ) produced in the spleen best predicted control of infection across all vaccine groups. Univariate logistic regression revealed vaccine-specific profiles of protection. High titers of ER-specific IgG serum antibodies together with IL-2 and IL-4 in the draining lymph node (DLN) were associated with protection induced by the ER vaccine. In contrast, high titers of IL-6, tumor necrosis factor alpha (TNF-α), IFN-γ, and IL-10 in the DLN and low IFN-γ titers in the spleen were associated with protection following BCG vaccination. This study suggests that an effective BU vaccine must induce localized, tissue-specific immune profiles with controlled inflammatory responses at the site of infection.
MeSH terms
- Mycobacterium ulcerans
- Buruli ulcer
- Biology
- Adjuvant
- Virology
- Microbiology
- Immune system
- Lipopeptide
- Mycobacterium tuberculosis
- Vaccination
- Immunology